IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D

Completed · Phase 4

Conditions studied: Abscess, Pain

In brief

The general objective of this study is to determine whether intranasal ketamine should be incorporated into formulary as an option to treat pain during minor procedures in the pediatric emergency department.

Key facts

Study ID

NCT02635282

Run by

University of Tennessee

People needed

19

Starts

2016-08-01

Expected to finish

2017-03-23

Last updated by the study team

2017-03-27

Who can join

Age: 3 and older, up to 17. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Diagnosis of abscess with planned incision and drainage of a single abscess

You may not qualify if…

• Fast Track patients
• Patients who have received an opioid analgesic within the previous 4 hours of time of enrollment in study
• Patients with parent or legal guardian not present to give informed consent for enrollment in study
• Non-English speaking patients and/or parent
• Patients with a contraindication for the administration of intranasal medication (nasal trauma, aberrant nasal anatomy)
• Patients with ocular injuries
• Patients with a known allergy to ketamine, fentanyl, and/or midazolam
• Pregnant females
• Patients with history of seizure disorders

Where it is running

• Le Bonheur Children's Hospital — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.